Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
Michal Yalon(Sheba Medical Center), Shoshana Paglin(Edmond and Lily Safra Children's Hospital)
Cited by 24
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells
|Cancer Research|2005|216
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
|Oncotarget|2018|15
Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2α
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0